https://www.selleckchem.com/products/ms-275.html
Although ticagrelor exerts an antibacterial activity, its effect on infections in patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI) is unclear. We aimed to assess whether ticagrelor and clopidogrel affect infections in these patients during hospitalization. A total of 2116 consecutive patients with STEMI undergoing PCI were divided into the ticagrelor (n=388) and clopidogrel (n=1728) groups. The primary outcome was infection onset. Secondary outcomes were in-hospital all-
Like
Comment
Share
